NCT02584933 2026-04-02Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored StudyNovartisPhase 4 Active not recruiting233 enrolled
NCT03849131 2025-03-12PRAISEUniversity Hospital, Strasbourg, FrancePhase 4 Active not recruiting905 enrolled